PCM
BDSI

Penn Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Penn Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-376,363
Closed -$1.58M – 249
2020
Q4 		$1.58M Sell
376,363
-875,716
-70% -$3.37M 0.2% 135
2020
Q3 		$4.67M Buy
1,252,079
+17,578
+1% +$74.8K 0.59% 68
2020
Q2 		$5.38M Buy
1,234,501
+94,800
+8% +$426K 0.7% 54
2020
Q1 		$4.32M Buy
1,139,701
+864,756
+315% +$4.25M 0.71% 53
2019
Q4 		$1.74M Sell
274,945
-483,517
-64% -$2.84M 0.18% 176
2019
Q3 		$3.19M Buy
758,462
+58,303
+8% +$249K 0.33% 116
2019
Q2 		$3.26M Buy
700,159
+404,120
+137% +$1.88M 0.32% 109
2019
Q1 		$1.57M Buy
296,039
+70,838
+31% +$323K 0.15% 166
2018
Q4 		$833K Buy
+225,201
New +$791K 0.08% 204
2016
Q1 		– Sell
-1,314,623
Closed -$6.3M – 281
2015
Q4 		$6.3M Buy
1,314,623
+84,031
+7% +$476K 0.28% 113
2015
Q3 		$6.84M Sell
1,230,592
-243,936
-17% -$1.8M 0.36% 113
2015
Q2 		$11.7M Buy
1,474,528
+330,427
+29% +$2.84M 0.48% 75
2015
Q1 		$12M Buy
+1,144,101
New +$15.6M 0.47% 75

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penn Capital Management's BDSI Position: Q1 2021 in Review

Penn Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 376,363 shares — an estimated $1.58M sold.

Penn Capital Management first reported a position in BDSI in Q1 2015 and held it in 13 quarters. The position peaked at $12M in Q1 2015. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

  • Penn Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
  • Penn Capital Management sold 376,363 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $1.58M.
  • Penn Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 13 quarters.
  • Penn Capital Management's BioDelivery Sciences International, Inc. position peaked at $12M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Penn Capital Management's 13F filing for Q1 2021, filed 13 May 2021.